Invention Application
- Patent Title: PARENTERAL NUTRITION FORMULATION COMPRISING VITAMIN B12
-
Application No.: PCT/EP2021/076321Application Date: 2021-09-24
-
Publication No.: WO2022063963A1Publication Date: 2022-03-31
- Inventor: DUPONT, Caroline , BOUREZG, Zouaoui , COUTHOUIS, Aurélie
- Applicant: BAXTER INTERNATIONAL INC. , BAXTER HEALTHCARE SA
- Applicant Address: One Baxter Parkway; Thurgauerstrasse 130
- Assignee: BAXTER INTERNATIONAL INC.,BAXTER HEALTHCARE SA
- Current Assignee: BAXTER INTERNATIONAL INC.,BAXTER HEALTHCARE SA
- Current Assignee Address: One Baxter Parkway; Thurgauerstrasse 130
- Agency: HERTIN UND PARTNER RECHTS- UND PATENTANWÄLTE
- Priority: EP20198426.7 2020-09-25
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K31/198 ; A61K31/4415 ; A61K31/455 ; A61K31/525 ; A61K31/714 ; A61P43/00 ; A61K9/08 ; A61K9/10 ; A61K47/44
Abstract:
The invention relates to a terminally heat-sterilized multi-chamber container for parenteral nutrition, comprising a first chamber containing a macronutrient formulation and a second chamber comprising a vitamin B12 formulation, wherein the vitamin B12 formulation (a) is essentially free from glucose, amino acids, vitamin B1, ascorbyl palmitate and/or vitamin C; and (b) stably comprises vitamin B12 for at least 6 months at a temperature of from 1°C to 40°C and/or for at least 24 months at a temperature of 25°C.
Information query